Literature DB >> 29401187

New Opportunities for Cancer Health Services Research: Linking the SEER-Medicare Data to the Nursing Home Minimum Data Set.

Kali S Thomas1,2, Eric Boyd3, Angela B Mariotto4, Dolly C Penn4, Michael J Barrett3, Joan L Warren4.   

Abstract

BACKGROUND: The Surveillance, Epidemiology and End Results (SEER)-Medicare data combine clinical information from population-based cancer registries with Medicare claims. These data have been used in many studies to understand cancer screening, treatment, outcomes, and costs. However, until recently, these data included limited information related to the characteristics and outcomes of cancer patients residing in or admitted to nursing homes.
OBJECTIVES: To provide an overview of the new linkage between SEER-Medicare data and the Minimum Data Set (MDS), a nursing home resident assessment instrument detailing residents' physical, psychological, and psychosocial functioning as well as any therapies or treatments received. RESEARCH
DESIGN: This is a descriptive, retrospective cohort study.
SUBJECTS: Persons in SEER-Medicare diagnosed with cancer from 2004 to 2013 were linked to the 2011-2014 MDS, with 17% of SEER-Medicare patients linked to the MDS data. During 2011-2014, we identified 318,617 cancer patients receiving care in a nursing home and 256,947 cancer patients newly admitted to a total of 10,953 nursing homes. Of these patients, approximately two thirds were Medicare fee-for-service beneficiaries.
RESULTS: The timing from cancer diagnoses to nursing home admission varied by cancer. In total, 93% of all patients were admitted directly to a nursing home from an acute care hospital. The majority of patients were cognitively intact, 21% reported some level of depression, and 9% had severe functional limitations.
CONCLUSIONS: The new SEER-Medicare-MDS dataset provides a valuable resource for understanding the postacute and long-term care experiences of cancer patients receiving care in United States' nursing homes.

Entities:  

Mesh:

Year:  2018        PMID: 29401187      PMCID: PMC6072629          DOI: 10.1097/MLR.0000000000000877

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  14 in total

1.  Analyses of nursing home residents in hospice care using the minimum data set.

Authors:  Robert J Buchanan; Maryann Choi; Suojin Wang; Chunfeng Huang
Journal:  Palliat Med       Date:  2002-11       Impact factor: 4.762

2.  Palliative care needs of cancer patients in U.S. nursing homes.

Authors:  Vanessa M P Johnson; Joan M Teno; Meg Bourbonniere; Vincent Mor
Journal:  J Palliat Med       Date:  2005-04       Impact factor: 2.947

3.  The accuracy of Minimum Data Set diagnoses in describing recent hospitalization at acute care facilities.

Authors:  Richard A Del Rio; Myla Goldman; B K Kapella; Loreto Sulit; Patrick K Murray
Journal:  J Am Med Dir Assoc       Date:  2006-03-03       Impact factor: 4.669

4.  Hospice Use and Pain Management in Elderly Nursing Home Residents With Cancer.

Authors:  Jacob N Hunnicutt; Jennifer Tjia; Kate L Lapane
Journal:  J Pain Symptom Manage       Date:  2016-12-29       Impact factor: 3.612

5.  MDS 3.0: brief interview for mental status.

Authors:  Debra Saliba; Joan Buchanan; Maria Orlando Edelen; Joel Streim; Joseph Ouslander; Dan Berlowitz; Joshua Chodosh
Journal:  J Am Med Dir Assoc       Date:  2012-07-15       Impact factor: 4.669

6.  The validity of the minimum data set in measuring the cognitive impairment of persons admitted to nursing homes.

Authors:  A L Gruber-Baldini; S I Zimmerman; E Mortimore; J Magaziner
Journal:  J Am Geriatr Soc       Date:  2000-12       Impact factor: 5.562

7.  Functional Improvement Among Short-Stay Nursing Home Residents in the MDS 3.0.

Authors:  Andrea Wysocki; Kali S Thomas; Vincent Mor
Journal:  J Am Med Dir Assoc       Date:  2015-02-03       Impact factor: 4.669

8.  Sensitivity and specificity of the Minimum Data Set 3.0 discharge data relative to Medicare claims.

Authors:  Momotazur Rahman; Denise Tyler; Joseph Kofi Acquah; Julie Lima; Vincent Mor
Journal:  J Am Med Dir Assoc       Date:  2014-08-30       Impact factor: 4.669

9.  Testing the PHQ-9 interview and observational versions (PHQ-9 OV) for MDS 3.0.

Authors:  Debra Saliba; Suzanne DiFilippo; Maria Orlando Edelen; Kurt Kroenke; Joan Buchanan; Joel Streim
Journal:  J Am Med Dir Assoc       Date:  2012-07-15       Impact factor: 4.669

10.  Temporal and Geographic variation in the validity and internal consistency of the Nursing Home Resident Assessment Minimum Data Set 2.0.

Authors:  Vincent Mor; Orna Intrator; Mark Aaron Unruh; Shubing Cai
Journal:  BMC Health Serv Res       Date:  2011-04-15       Impact factor: 2.655

View more
  4 in total

1.  Functional Status and Survival in Older Nursing Home Residents With Advanced Non-Small-Cell Lung Cancer: A SEER-Medicare Analysis.

Authors:  Michael A Liu; Tamra Keeney; Alexa Papaila; Jessica Ogarek; Humera Khurshid; Elizabeth Wulff-Burchfield; Adam Olszewski; Emmanuelle Bélanger; Orestis A Panagiotou
Journal:  JCO Oncol Pract       Date:  2022-02-07

Review 2.  Updated Overview of the SEER-Medicare Data: Enhanced Content and Applications.

Authors:  Lindsey Enewold; Helen Parsons; Lirong Zhao; David Bott; Donna R Rivera; Michael J Barrett; Beth A Virnig; Joan L Warren
Journal:  J Natl Cancer Inst Monogr       Date:  2020-05-01

3.  Home Health Use Following a Cancer Diagnosis Among Patients Enrolled in Medicare Advantage and Traditional Medicare: Findings From the Newly Linked SEER-Medicare and Home Health OASIS Data.

Authors:  Kali S Thomas; Margot L Schwartz; Eric Boyd; Dolly P White; Angela B Mariotto; Michael J Barrett; Joan L Warren
Journal:  J Natl Cancer Inst Monogr       Date:  2020-05-01

4.  Prevalence of functional limitations and their associations with systemic cancer therapy among older adults in nursing homes with advanced non-small cell lung cancer.

Authors:  Orestis A Panagiotou; Tamra Keeney; Jessica A Ogarek; Elizabeth Wulff-Burchfield; Adam J Olszewski; Emmanuelle Bélanger
Journal:  J Geriatr Oncol       Date:  2021-02-18       Impact factor: 3.929

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.